'Front and center': Industry leaders call for response to Supreme Court abortion case draft

Kyle LaHucik

Senior Reporter

Biotech industry leaders want the drug development world to stand up and ensure employees have access to abortions after a draft ruling last week revealed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

'Front and center': Industry leaders call for response to Supreme Court abortion case draft

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

The election is Tuesday. What’s at stake for the pharma industry?

'We play to win': AstraZeneca details first results for oral GLP-1 and broader obesity ambitions

Is there room for MASH drugs in a GLP-1 world?

Viking's oral weight loss drug appears to have strong effect in Phase 1 trial

FDA cites Mark Cuban's drug compounding center in Dallas with sterility, quality concerns

Gene therapies don’t have to cost $4 million: New production platforms reduce development costs and risks

'Front and cen­ter': In­dus­try lead­ers call for re­sponse to Supreme Court abor­tion case draft

Senior Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

'Front and center': Industry leaders call for response to Supreme Court abortion case draft